MichaelElliottBigbyMD

PubMed

• 1 citations
  Letter to the editor.
  Samuel Zagarella, Michael Bigby, Michael Sladden, Catalin Popescu> ;Journal of the American Academy of Dermatology. 2023 Jan 1
• 4 citations
  Platelet-rich plasma lacks evidence of clinically significant improvement in androgenetic alopecia.
  Michael Bigby, Ramon Grimalt> ;Journal of the American Academy of Dermatology. 2021 Apr 1
• 3 citations
  The sentinel node biopsy has not come of age
  Michael J Sladden, Samuel Zagarella, Catalin M. Popescu, Michael Bigby> ;The British Journal of Dermatology. 2020 Feb 1
• 2 citations
  Rifampin and clindamycin are safe long-term: Response to "North American clinical management guidelines for hidradenitis suppurativa: A publication from the United Sta...
  Joerg Albrecht, Michael Bigby> ;Journal of the American Academy of Dermatology. 2019 Sep 27
• Comment on "Re-evaluating the need for routine laboratory monitoring on isotretinoin patients: A retrospective analysis".
  Joerg Albrecht, Owen N. Kramer, Michael Bigby> ;Journal of the American Academy of Dermatology. 2021 Dec 1
• 30 citations
  Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa. A Critically Appraised Topic.
  Joerg Albrecht, P.A. Baine, B. Ladizinski, Gregor B.E. Jemec, Michael Bigby> ;The British Journal of Dermatology. 2019 Apr 1
• 19 citations
  Time to reconsider the role of sentinel lymph node biopsy in melanoma
  Michael Bigby, Samuel Zagarella, Michael J Sladden, Catalin M. Popescu> ;Journal of the American Academy of Dermatology. 2019 Apr 1
• 2 citations
  'Role of sentinel lymph node biopsy as a staging procedure in patients with melanoma: A critical appraisal' by Omgo E Nieweg, Alan Cooper and John F Thompson.
  Samuel Zagarella, Michael J Sladden, Catalin M. Popescu, Michael Bigby> ;The Australasian Journal of Dermatology. 2018 May 1
• 1 citations
  When is a sentinel node biopsy indicated for patients with primary melanoma? Comment on the 'Australian guidelines for the management of cutaneous melanoma'.
  Michael J Sladden, Samuel Zagarella, Catalin M. Popescu, Michael Bigby> ;The Australasian Journal of Dermatology. 2018 May 1
• 3 citations
  Development of resistance to Mycobacterium tuberculosis is manageable in hidradenitis suppurativa. Response to 'Treatment of hidradenitis suppurativa with rifampicin: ...
  Joerg Albrecht, S. Mehta, Michael Bigby> ;The British Journal of Dermatology. 2018 Jan 1
• 23 citations
  Not every patient needs a triglyceride check, but all can get pancreatitis: a systematic review and clinical characterization of isotretinoin-associated pancreatitis.
  D. Opel, Owen N. Kramer, M. Chevalier, Michael Bigby, Jörg Albrecht> ;The British Journal of Dermatology. 2017 Oct 1
• 161 citations
  Rates of cutaneous reactions to drugs.
  Michael Bigby> ;Archives of Dermatology. 2001 Jun 1
• 4 citations
  Sentinel lymph node biopsy in melanoma.
  Michael Bigby, Catalin M. Popescu> ;BMJ. 2015 Nov 10
• 7 citations
  Pityriasis versicolor.
  Sruthi Renati, Anthony Cukras, Michael Bigby> ;BMJ. 2015 Apr 7
• 35 citations
  No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial‐I final report
  Michael J Sladden, Samuel Zagarella, Catalin M. Popescu, Michael Bigby> ;The British Journal of Dermatology. 2015 Mar 1
• Sentinel lymph node biopsy for melanoma: an important risk-stratification tool.
  Samuel Zagarella, Michael J Sladden, Catalin M. Popescu, Michael Bigby> ;The Medical Journal of Australia. 2015 Feb 2
• 13 citations
  Evaluating the Strength of Clinical Recommendations in the Medical Literature: GRADE, SORT, and AGREE
  Mayra B.C. Maymone, Stephanie D. Gan, Michael Bigby> ;The Journal of Investigative Dermatology. 2014 Oct 1
• 3 citations
  Interventions for mycosis fungoides: critical commentary on a Cochrane Systematic Review.
  Peggy A. Wu, Victor Huang, Michael Bigby> ;The British Journal of Dermatology. 2014 May 1
• 11 citations
  Understanding and evaluating systematic reviews and meta-analyses
  Michael Bigby> ;Indian Journal of Dermatology. 2014 Mar 1
• 1 citations
  Practicing prevention with probiotics.
  Vinod E. Nambudiri, Michael Bigby> ;JAMA Dermatology. 2013 Dec 1
• 3 citations
  Risk of Malignant Disease and Biologic Response Modifiers: Fact, Fiction, and Future Concerns
  Vinod E. Nambudiri, Michael Bigby> ;JAMA Dermatology. 2013 Oct 1
• 56 citations
  Urban legends series: lichen planus
  Lorena Baccaglini, Kobkan Thongprasom, Marco Carrozzo, Michael Bigby> ;Oral Diseases. 2013 Mar 1
• 3 citations
  The weight of evidence on the association of isotretinoin use and the development of inflammatory bowel disease.
  Catalin M. Popescu, Michael Bigby> ;JAMA Dermatology. 2013 Feb 1
• Outcome Measures in Dermatology: Comment on “Measurement Properties of Outcome Measures for Vitiligo”
  Michael Bigby> ;Archives of Dermatology. 2012 Nov 1
• 327 citations
  AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, Ame...
  Suzanne M. Connolly, Diane Baker, Brett M. Coldiron, Michael J. Fazio, Paul A. Storrs, Allison T. Vidimos, Mark J. Zalla, Jerry D. Brewer, Wendy Smith Begolka, Timothy...> ;Journal of the American Academy of Dermatology. 2012 Oct 1
• Join now to see all